Zhouao Zhang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Replacement Therapy

Myasthenia Gravis

Top Venues

Annals of clinical and translational neurology

Therapeutic advances in neurological disorders

Journal of neurochemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Zhouao Zhang, Mingjin Yang, Tiancheng Luo, Xue Du, Zhouyi Wang, Xiaoyu Huang, Xiaoyu Huang
Rescue treatment with add-on efgartigimod in a patient with impending myasthenic crisis: a case report. Therapeutic advances in neurological disorders 17 (2024)
Zhouao Zhang, Mingjin Yang, Tiancheng Luo, Xue Du, Zhouyi Wang, Xiaoyu Huang, Xiaoyu Huang
Rescue treatment with add-on efgartigimod in a patient with impending myasthenic crisis: a case report. Therapeutic advances in neurological disorders 17 (2024)
Su-Shan Luo, Qilong Jiang, Wenshuang Zeng, Qinzhou Wang, Zhang-Yu Zou, Yanyan Yu, Dao-Jun Hong, Quantao Zeng, Song Tan, Zhouao Zhang, Xiaoyu Huang, Xiuming Guo, Jing Chen, Zhongyan Zhao, Shixiong Huang, Jian-Quan Shi, Ying Chen, Lei Du, Chong Yan, Jianying Xi, Jie Song, Chong-Bo Zhao, null null
Efgartigimod for generalized myasthenia gravis: A multicenter real-world cohort study in China. Annals of clinical and translational neurology (2024)
Su-Shan Luo, Qilong Jiang, Wenshuang Zeng, Qinzhou Wang, Zhang-Yu Zou, Yanyan Yu, Dao-Jun Hong, Quantao Zeng, Song Tan, Zhouao Zhang, Xiaoyu Huang, Xiuming Guo, Jing Chen, Zhongyan Zhao, Shixiong Huang, Jian-Quan Shi, Ying Chen, Lei Du, Chong Yan, Jianying Xi, Jie Song, Chong-Bo Zhao, null null
Efgartigimod for generalized myasthenia gravis: A multicenter real-world cohort study in China. Annals of clinical and translational neurology 11 (8) (2024)
Su-Shan Luo, Qilong Jiang, Wenshuang Zeng, Qinzhou Wang, Zhang-Yu Zou, Yanyan Yu, Dao-Jun Hong, Quantao Zeng, Song Tan, Zhouao Zhang, Xiaoyu Huang, Xiuming Guo, Jing Chen, Zhongyan Zhao, Shixiong Huang, Jian-Quan Shi, Ying Chen, Lei Du, Chong Yan, Jianying Xi, Jie Song, Chong-Bo Zhao, null null
Efgartigimod for generalized myasthenia gravis: A multicenter real-world cohort study in China. Annals of clinical and translational neurology 11 (8) (2024)
Su-Shan Luo, Qilong Jiang, Wenshuang Zeng, Qinzhou Wang, Zhang-Yu Zou, Yanyan Yu, Dao-Jun Hong, Quantao Zeng, Song Tan, Zhouao Zhang, Xiaoyu Huang, Xiuming Guo, Jing Chen, Zhongyan Zhao, Shixiong Huang, Jian-Quan Shi, Ying Chen, Lei Du, Chong Yan, Jianying Xi, Jie Song, Chong-Bo Zhao, null null
Efgartigimod for generalized myasthenia gravis: A multicenter real-world cohort study in China. Annals of clinical and translational neurology 11 (8) (2024)
Zhouao Zhang, Xiaoyu Huang, Xue Du, Zhouyi Wang, Yingying Wang, Mingming Xu, Xiao Chen, Qian Yao, Lisha Yan, Yong Zhang
Plasma C18:0-ceramide is a novel potential biomarker for disease severity in myasthenia gravis. Journal of neurochemistry (2023)